AS: Treatment Guidelines

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA) into one set applicable to the full spectrum of patients with axSpA. Following the latest version of the European…

Axial Spondyloarthritis Treatment Recommendations

In this slideshow, we highlight the 13 ASAS-EULAR treatment management guidelines for axial spondyloarthritis.

Review: Axial Spondyloarthritis Treatment Guidelines

Updated EULAR guidelines for axial spondyloarthritis raise more questions than answers about biologic…

BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics

Treatment algorithm for biologic therapy in axSpA

© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.comankylosing spondylitis, axial spondyloarthritis, anti-TNF, biologic, guideline, treatment…Axial SpA (axSpA) is…

American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

An external file that holds a picture, illustration, etc. Object name is nihms822813f3.jpg

To provide evidence‐based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA).A core group led the development of the recommendations,…

Fine-Tuning Treatment for Ankylosing Spondylitis

Focus is on specific clinical situations, and hope now is for guideline update in light of new options